Nephros (NEPH) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.28% |
| Dec 31, 2025 | 15.83% |
| Sep 30, 2025 | 18.71% |
| Jun 30, 2025 | 16.56% |
| Mar 31, 2025 | 20.51% |
| Dec 31, 2024 | 25.00% |
| Sep 30, 2024 | 17.57% |
| Jun 30, 2024 | 20.57% |
| Mar 31, 2024 | 33.44% |
| Dec 31, 2023 | 3.78% |
| Sep 30, 2023 | 18.74% |
| Jun 30, 2023 | 9.10% |
| Mar 31, 2023 | 24.57% |
| Dec 31, 2022 | -7.23% |
| Sep 30, 2022 | -16.19% |
| Jun 30, 2022 | -1.43% |
| Mar 31, 2022 | -18.32% |
| Dec 31, 2021 | -1.59% |
| Sep 30, 2021 | -2.93% |
| Jun 30, 2021 | -5.87% |
| Mar 31, 2021 | -4.65% |
| Dec 31, 2020 | 5.07% |
| Sep 30, 2020 | 2.80% |
| Jun 30, 2020 | -21.91% |
| Mar 31, 2020 | -5.50% |
| Dec 31, 2019 | 19.06% |
| Sep 30, 2019 | 0.08% |
| Jun 30, 2019 | -6.96% |
| Mar 31, 2019 | -12.22% |
| Dec 31, 2018 | 8.37% |
| Sep 30, 2018 | 2.43% |
| Jun 30, 2018 | -0.84% |
| Mar 31, 2018 | -3.20% |
| Dec 31, 2017 | 15.26% |
| Sep 30, 2017 | 6.64% |
| Jun 30, 2017 | 1.21% |
| Mar 31, 2017 | -3.84% |
| Dec 31, 2016 | -0.95% |
| Sep 30, 2016 | -10.63% |
| Jun 30, 2016 | -7.22% |
| Mar 31, 2016 | -4.47% |
| Dec 31, 2015 | -9.43% |
| Sep 30, 2015 | -22.77% |
| Jun 30, 2015 | -10.56% |